Items where authors include "Trenell, MI"

Article

Campbell, MD orcid.org/0000-0001-5883-5041, Walker, M, Trenell, MI et al. (8 more authors) (2014) Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial. PLoS ONE, 9 (5). e97143. ISSN 1932-6203

Campbell, MD orcid.org/0000-0001-5883-5041, Walker, M, Trenell, MI et al. (5 more authors) (2013) Large Pre- and Postexercise Rapid-Acting Insulin Reductions Preserve Glycemia and Prevent Early- but Not Late-Onset Hypoglycemia in Patients With Type 1 Diabetes. Diabetes Care, 36 (8). pp. 2217-2224. ISSN 0149-5992

Proceedings Paper

Campbell, MD orcid.org/0000-0001-5883-5041, Walker, M, Trenell, MI et al. (5 more authors) (2015) A combined basal-bolus insulin dose reduction strategy for preventing exercise-induced hypoglycaemia does not cause hormonal, metabolic or inflammatory disturbances in Type 1 diabetes. In: Diabetic Medicine. Diabetes UK Professional Conference, 11-13 Mar 2015, London, UK. Wiley , pp. 53-54.

Campbell, MD orcid.org/0000-0001-5883-5041, Walker, M, Trenell, MI et al. (6 more authors) (2015) A novel strategy that prevents early- and late-onset nocturnal hypoglycaemia following evening exercise in Type 1 diabetes. In: Diabetic Medicine. Diabetes UK Professional Conference, 11-13 Mar 2015, London, UK. Wiley , p. 51.

Campbell, MD orcid.org/0000-0001-5883-5041, West, DJ, Simpson, P et al. (1 more author) (2014) Investigation of glycaemic control in elite and recreationally-active individuals with and without type 1 diabetes mellitus during multi-day ultra-distance exercise: 2014 mHealth grand tour. In: Diabetologia. 50th EASD Annual Meeting of the European Association for the Study of Diabetes, 15-19 Sep 2014, Vienna, Austria. Springer Verlag , S256-S256.

Campbell, MD orcid.org/0000-0001-5883-5041, Walker, M, Trenell, MI et al. (7 more authors) (2014) Heavily reducing pre- and post-exercise rapid-acting insulin dose may cause hyperglycaemia, but does not augment ketonaemia or increase inflammatory cytokines in patients with Type 1 diabetes. In: Diabetic Medicine. Diabetes UK Annual Professional Conference 2014, 05-07 Mar 2014, Liverpool, UK. Wiley , pp. 69-70.

Campbell, MD orcid.org/0000-0001-5883-5041, Walker, M, Trenell, MI et al. (6 more authors) (2013) Preventing hypoglycaemia by heavily reducing pre- and postexercise rapid-acting insulin dose may cause hyperglycaemia, but not hyperketonaemia in type 1 diabetes patients. In: Diabetologia. 49th EASD Annual Meeting of the European Association for the Study of Diabetes, 23-27 Sep 2013, Barcelona, Spain. Springer Verlag , S277-S278.

Campbell, MD orcid.org/0000-0001-5883-5041, Walker, M, Trenell, MI et al. (6 more authors) (2013) The preservation of glycaemia through large pre- and post-exercise rapid-acting insulin reductions prevents early but not late-onset hypoglycaemia in individuals with Type 1 diabetes. In: Diabetic Medicine. Diabetes UK Professional Conference 2013, 13-15 Mar 2013, Manchester, UK. Wiley , p. 46.